InvestorsHub Logo
Followers 3
Posts 207
Boards Moderated 0
Alias Born 07/22/2016

Re: None

Friday, 04/12/2019 3:07:24 PM

Friday, April 12, 2019 3:07:24 PM

Post# of 38634
Ranexa patents expire May 27, 2019, 45 days. I tried writing investors relation to remind them of the important date. FDA will probably giving out final approvals after the patents expire.

IPCI should be building up inventory and preparing for Generic Ranexa launch. IPCI can either distribute it themselves or find a partner. Mallinckrodt did a poor job with Seroquel XR. I would suggest finding a better partner for non-opioids. Mallinckrodt specializes in opioids, so maybe they would be a good partner for IPCI's Oxy ER.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y